Patents Assigned to The University of Colorado
  • Patent number: 5126348
    Abstract: Vasodilators and theophylline.
    Type: Grant
    Filed: September 26, 1989
    Date of Patent: June 30, 1992
    Assignee: The University of Colorado Foundation, Inc.
    Inventor: William H. McMurray
  • Patent number: 5115428
    Abstract: A series array architecture using multiple photonic stages perform universal permutation of time-slots on a time-multiplexed photonic signal using far fewer switches than the currently known architectures. The array architectures include Serial switch arrays with feed-forward delay, Serial switch arrays with feedback delay using shift-base of 2, and Serial switch arrays with feedback delay using shift-base of 3. The array has multiple stages where each can be described as the temporal equivalent of spatial interconnection networks.
    Type: Grant
    Filed: September 5, 1989
    Date of Patent: May 19, 1992
    Assignee: The University of Colorado Foundation, Inc.
    Inventors: Srinivasan V. Ramanan, Harry F. Jordan
  • Patent number: 5110624
    Abstract: Magnetizable, porous particles are prepared by contacting a first portion of porous particles with a suspension comprised of magnetite particles, coated with a dispersing agent, and water, removing and discarding the first portion of porous particles, contacting the suspension with a second portion of porous particles, and separating the second portion of porous particles from the suspension. The magnetizable, second portion of porous particles may be ion exchange resin particles used in a magnetically stabilized fluidized bed to isolate proteins from cell lysate.
    Type: Grant
    Filed: March 26, 1991
    Date of Patent: May 5, 1992
    Assignee: The University of Colorado Foundation, Inc.
    Inventors: Richard D. Noble, Carl A. Koval, Lori Nixon, Geoffrey F. Slaff
  • Patent number: 5089466
    Abstract: Stable mixed metal oxide compositions containing nitrogen are formed by treating an oxygen-deficient perovskite composition with nitrogen dioxide. Preferably, the oxygen-deficient perovskite is of the formula X.sub.a Z.sub.b Cu.sub.c O.sub.h wherein X is a member selected from the group consisting of yttrium, scandium, lanthanum, neodymium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, bismuth and thallium, Z is a member selected from the group consisting of barium, strontium, calcium, magnesium and mixtures thereof, a is not less than 1, b is from 0 to 3, c is from 0 to 3, and h is not greater than about 6, and the mixed metal oxides are of the formula X.sub.a Z.sub.b Cu.sub.c N.sub.j O.sub.k where X, Z, a, b and c are as previously defined, j is from about 0.001 to about 3, and k is from about 6 to about 13.
    Type: Grant
    Filed: July 8, 1988
    Date of Patent: February 18, 1992
    Assignee: The University of Colorado Foundation, Inc.
    Inventors: Robert E. Sievers, Stephen A. Montzka
  • Patent number: 5084169
    Abstract: Magnetically stabilized fluidized bed technology is utilized in conjunction with ion-exchange adsorption/desorption processes in a method and system for isolating proteins from cell lysate. The invention also includes a magnetizable, porous, ion-exchange particle, and a method for producing the same, for use with the stationary magnetically stabilized fluidized bed protein isolation process.
    Type: Grant
    Filed: September 19, 1989
    Date of Patent: January 28, 1992
    Assignee: The University of Colorado Foundation, Inc.
    Inventors: Richard D. Noble, Carl A. Koval, Lori Nixon, Geoffrey F. Slaff
  • Patent number: 4943524
    Abstract: A procedure for the immunoassay of a proteolytic procoagulant enzyme in biological samples is described. The presence of the enzyme is indicative of malignant disease, and the immunoassay is used as a diagnostic test for cancer.
    Type: Grant
    Filed: February 17, 1989
    Date of Patent: July 24, 1990
    Assignee: The University of Colorado Foundation, Inc.
    Inventor: Stuart G. Gordon
  • Patent number: 4835295
    Abstract: Chiral, nonracemic compounds of the general formula: ##STR1## wherein n=1 or 2, Y is a hydrogen, fluorine, chlorine or bromine atom, R' is an alkyl or alkoxy group having three to fifteen carbons, and R is an alkyl group having three to fifteen carbons, which are useful as ferroelectric liquid crystal components having high polarization are described. Also described are compounds of the same general formula in which X is OH, which are useful as synthetic intermediates in the preparation of the FLC components of the present invention.
    Type: Grant
    Filed: September 21, 1987
    Date of Patent: May 30, 1989
    Assignee: The University of Colorado Foundation, Inc.
    Inventors: David M. Walba, Homaune A. Razavi